Pulsed Blue Light and Phage Therapy: A Novel Synergistic Bactericide.

IF 4.3 2区 医学 Q1 INFECTIOUS DISEASES
Amit Rimon, Jonathan Belin, Ortal Yerushalmy, Yonatan Eavri, Anatoly Shapochnikov, Shunit Coppenhagen-Glazer, Ronen Hazan, Lilach Gavish
{"title":"Pulsed Blue Light and Phage Therapy: A Novel Synergistic Bactericide.","authors":"Amit Rimon, Jonathan Belin, Ortal Yerushalmy, Yonatan Eavri, Anatoly Shapochnikov, Shunit Coppenhagen-Glazer, Ronen Hazan, Lilach Gavish","doi":"10.3390/antibiotics14050481","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Antibiotic-resistant <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) strains are an increasing cause of morbidity and mortality. Pulsed blue light (PBL) enhances porphyrin-induced reactive oxygen species and has been clinically shown to be harmless to the skin at low doses. Bacteriophages, viruses that infect bacteria, offer a promising non-antibiotic bactericidal approach. This study investigates the potential synergism between low-dose PBL and phage therapy against <i>P. aeruginosa</i> in planktonic cultures and preformed biofilms. <b>Methods:</b> We conducted a factorial dose-response in vitro study combining <i>P. aeruginosa-specific</i> phages with PBL (457 nm, 33 kHz) on both PA14 and multidrug-resistant PATZ2 strains. After excluding direct PBL effects on phage titer or activity, we assessed effectiveness on planktonic cultures using growth curve analysis (via <i>growth_curve_outcomes</i>, a newly developed, Python-based tool available on GitHub) , CFU, and PFU. Biofilm efficacy was evaluated using CFU post-sonication, crystal violet staining, and live/dead staining with confocal microscopy. Finally, we assessed reactive oxygen species (ROS) as a potential mechanism using the nitro blue tetrazolium reduction assay. ANOVA or Kruskal-Wallis tests with post hoc Tukey or Conover-Iman tests were used for comparisons (<i>n</i> = 5 biological replicates and technical triplicates). <b>Results:</b> The bacterial growth lag phase was significantly extended for phage alone or PBL alone, with a synergistic effect of up to 144% (<i>p</i> < 0.001 for all), achieving a 9 log CFU/mL reduction at 24 h (<i>p</i> < 0.001). In preformed biofilms, synergistic combinations significantly reduced biofilm biomass and bacterial viability (% Live, median (IQR): Control 80%; Phage 40%; PBL 25%; PBL&Phage 15%, <i>p</i> < 0.001). Mechanistically, PBL triggered transient ROS in planktonic cultures, amplified by phage co-treatment, while a biphasic ROS pattern in biofilms reflected time-dependent synergy. <b>Conclusions:</b> Phage therapy combined with PBL demonstrates a synergistic bactericidal effect against <i>P. aeruginosa</i> in both planktonic cultures and biofilms. Given the strong safety profile of PBL and phages, this approach may lead to a novel, antibiotic-complementary, safe treatment modality for patients suffering from difficult-to-treat antibiotic-resistant infections and biofilm-associated infections.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"14 5","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2025-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12108478/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antibiotics-Basel","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/antibiotics14050481","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Antibiotic-resistant Pseudomonas aeruginosa (P. aeruginosa) strains are an increasing cause of morbidity and mortality. Pulsed blue light (PBL) enhances porphyrin-induced reactive oxygen species and has been clinically shown to be harmless to the skin at low doses. Bacteriophages, viruses that infect bacteria, offer a promising non-antibiotic bactericidal approach. This study investigates the potential synergism between low-dose PBL and phage therapy against P. aeruginosa in planktonic cultures and preformed biofilms. Methods: We conducted a factorial dose-response in vitro study combining P. aeruginosa-specific phages with PBL (457 nm, 33 kHz) on both PA14 and multidrug-resistant PATZ2 strains. After excluding direct PBL effects on phage titer or activity, we assessed effectiveness on planktonic cultures using growth curve analysis (via growth_curve_outcomes, a newly developed, Python-based tool available on GitHub) , CFU, and PFU. Biofilm efficacy was evaluated using CFU post-sonication, crystal violet staining, and live/dead staining with confocal microscopy. Finally, we assessed reactive oxygen species (ROS) as a potential mechanism using the nitro blue tetrazolium reduction assay. ANOVA or Kruskal-Wallis tests with post hoc Tukey or Conover-Iman tests were used for comparisons (n = 5 biological replicates and technical triplicates). Results: The bacterial growth lag phase was significantly extended for phage alone or PBL alone, with a synergistic effect of up to 144% (p < 0.001 for all), achieving a 9 log CFU/mL reduction at 24 h (p < 0.001). In preformed biofilms, synergistic combinations significantly reduced biofilm biomass and bacterial viability (% Live, median (IQR): Control 80%; Phage 40%; PBL 25%; PBL&Phage 15%, p < 0.001). Mechanistically, PBL triggered transient ROS in planktonic cultures, amplified by phage co-treatment, while a biphasic ROS pattern in biofilms reflected time-dependent synergy. Conclusions: Phage therapy combined with PBL demonstrates a synergistic bactericidal effect against P. aeruginosa in both planktonic cultures and biofilms. Given the strong safety profile of PBL and phages, this approach may lead to a novel, antibiotic-complementary, safe treatment modality for patients suffering from difficult-to-treat antibiotic-resistant infections and biofilm-associated infections.

脉冲蓝光与噬菌体疗法:一种新型协同杀菌剂。
背景:耐抗生素铜绿假单胞菌(P. aeruginosa)菌株是引起发病率和死亡率增加的原因。脉冲蓝光(PBL)增强卟啉诱导的活性氧,临床证明在低剂量下对皮肤无害。噬菌体,一种感染细菌的病毒,提供了一种很有前途的非抗生素杀菌方法。本研究探讨了低剂量PBL与噬菌体治疗在浮游培养物和预成型生物膜中对铜绿假单胞菌的潜在协同作用。方法:将铜绿假单胞菌特异性噬菌体与PBL (457 nm, 33 kHz)结合,对PA14和多药耐药的PATZ2菌株进行了体外因子剂量效应研究。在排除PBL对噬菌体滴度或活性的直接影响后,我们使用生长曲线分析(通过growth_curve_outcomes,一种新开发的基于python的GitHub工具)、CFU和PFU来评估浮游培养物的有效性。使用CFU超声后、结晶紫染色和共聚焦显微镜活/死染色来评估生物膜的效果。最后,我们评估了活性氧(ROS)作为一个潜在的机制,使用硝基蓝四氮唑还原试验。采用方差分析或Kruskal-Wallis检验和事后Tukey或Conover-Iman检验进行比较(n = 5个生物重复和技术重复)。结果:单独使用噬菌体或单独使用PBL均可显著延长细菌生长滞后期,其协同效应高达144% (p < 0.001), 24 h可降低9 log CFU/mL (p < 0.001)。在预成型生物膜中,增效组合显著降低了生物膜生物量和细菌活力(% Live,中位数(IQR):对照80%;噬菌体40%;PBL 25%;PBL&Phage 15%, p < 0.001)。从机制上讲,PBL在浮游培养物中触发了短暂的ROS,通过噬菌体共处理放大,而生物膜中的双相ROS模式反映了时间依赖性协同作用。结论:噬菌体联合PBL在浮游培养物和生物膜中对铜绿假单胞菌均有协同杀菌作用。鉴于PBL和噬菌体的强安全性,这种方法可能会为患有难以治疗的抗生素耐药感染和生物膜相关感染的患者带来一种新的、抗生素互补的安全治疗方式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Antibiotics-Basel
Antibiotics-Basel Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
CiteScore
7.30
自引率
14.60%
发文量
1547
审稿时长
11 weeks
期刊介绍: Antibiotics (ISSN 2079-6382) is an open access, peer reviewed journal on all aspects of antibiotics. Antibiotics is a multi-disciplinary journal encompassing the general fields of biochemistry, chemistry, genetics, microbiology and pharmacology. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Therefore, there is no restriction on the length of papers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信